OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
🇺🇸United States
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-11-16
- Last Posted Date
- 2015-02-13
- Target Recruit Count
- 133
- Registration Number
- NCT01727700
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
- First Posted Date
- 2012-11-16
- Last Posted Date
- 2015-10-16
- Target Recruit Count
- 110
- Registration Number
- NCT01727713
A Phase 1, Open-label, Multiple Dose Escalation Trial to Determine Safety and Tolerability of Once Daily OPB-111077 in Subjects With Advanced Cancer
- First Posted Date
- 2012-10-22
- Last Posted Date
- 2016-04-05
- Target Recruit Count
- 145
- Registration Number
- NCT01711034
Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
- First Posted Date
- 2012-10-19
- Last Posted Date
- 2018-09-21
- Target Recruit Count
- 748
- Registration Number
- NCT01710709
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-10-05
- Last Posted Date
- 2014-01-17
- Target Recruit Count
- 92
- Registration Number
- NCT01702181
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
- First Posted Date
- 2012-09-11
- Last Posted Date
- 2015-03-31
- Target Recruit Count
- 74
- Registration Number
- NCT01683058
Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder
- First Posted Date
- 2012-08-22
- Last Posted Date
- 2016-02-04
- Target Recruit Count
- 18
- Registration Number
- NCT01670279
- Locations
- 🇺🇸
Accurate Clinical Trials, Kissimmee, Florida, United States
🇺🇸Miami Jewish Health System, Miami, Florida, United States
🇺🇸St. Louis Clinical Trials, St. Louis, Missouri, United States
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
- First Posted Date
- 2012-08-20
- Last Posted Date
- 2017-01-13
- Target Recruit Count
- 524
- Registration Number
- NCT01668797
Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
- First Posted Date
- 2012-08-13
- Last Posted Date
- 2015-02-16
- Target Recruit Count
- 340
- Registration Number
- NCT01663532
Multicenter, Open-label, Safety and Tolerability Study
- First Posted Date
- 2012-07-25
- Last Posted Date
- 2015-10-29
- Target Recruit Count
- 244
- Registration Number
- NCT01649557
- Locations
- 🇺🇦
Otsuka Investigational Site, Vinnytsya, Ukraine
© Copyright 2024. All Rights Reserved by MedPath